Sepiolite–Chitosan–Acetic Acid Biocomposite Attenuates the Development of Obesity and Nonalcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet
Nutrients · 2024
DOI: 10.3390/nu16223958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Dalia Niv und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Integrative Physiology, The Department of Nutrition and Natural Products, MIGAL-Galilee Research Institute, P.O. Box 831, Kiryat Shmona…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diet, High-Fat, Obesity, Mice, Inbred C57BL. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israeli Ministry of Industry, Trade & Labor KAMIN, Israeli Ministry of Science, Technology, and Space, European Union's Seventh Framework Programme FP7-REGPOT-2012-2013-1.
Abstract (Originalsprache)
Background; obesity and nonalcoholic fatty liver disease (NAFLD) reduce life expectancy; nonoperative interventions show poor results. Individually, chitosan (1% w/w), acetic acid (AA 0.3–6.5% w/w), and sepiolite clay (5% w/w) attenuate high-fat-diet-induced obesity (DIO) via reduced energy digestibility and increased energy expenditure. Objectives; therefore, we hypothesized that a chitosan–sepiolite biocomposite suspended in AA would attenuate DIO and NAFLD to a greater extent than AA alone via its more substantial adsorption of nonpolar molecules. Methods; we tested this dietary supplement in C57BL/6J mice fed a high-fat diet (HFD) compared to an unsupplemented HFD and an HFD supplemented with a bile acid sequestrant (cholestyramine) or standalone AA. Results; biocomposite supplementation reduced DIO gain by 60% and abolished hepatic liver accumulation, whereas standalone AA showed mild attenuation of DIO gain and did not prevent HFD-induced hepatic fat accumulation. The biocomposite intake was accompanied by a lower digestibility (−4 point %) counterbalanced by increased intake; hence, it did not affect energy absorption. Therefore, DIO attenuation was suggested to be related to higher energy expenditure, a phenomenon not found with AA alone, as supported by calculated energy expenditure using the energy balance method. Conclusions; these results support further investigation of the biocomposite’s efficacy in attenuating obesity and NAFLD, specifically when applied with a restricted diet. Future studies are needed to determine this biocomposite’s safety, mechanism of action, and efficacy compared to its components given separately or combined with other ingredients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Integrative Physiology, The Department of Nutrition and Natural Products, MIGAL-Galilee Research Institute, P.O. Box 831, Kiryat Shmona 11016, Israel.
- Environmental Physical Chemistry Laboratory, MIGAL-Galilee Research Institute, P.O. Box 831, Kiryat Shmona 11016, Israel.
- Departments of Environmental and Water Sciences, Faculty of Sciences and Technology, Tel-Hai College, Upper Galilee 12210, Israel.
- Department of Animal Sciences, Faculty of Sciences and Technology, Tel-Hai College, Upper Galilee 12210, Israel.
ORCID-Profile: Giora Rytwo, Roee Gutman
Förderung
- Israeli Ministry of Industry, Trade & Labor KAMIN
- Israeli Ministry of Science, Technology, and Space
- European Union's Seventh Framework Programme FP7-REGPOT-2012-2013-1
- Israeli Ministry of Industry, Trade and Labor KAMIN
- European Union’s Seventh Framework Programme FP7-REGPOT-2012-2013-1
Zitieren
APA
Niv, D., Anavi, E., Yaval, L., Abbas, A., Rytwo, G., & Gutman, R. (2024). Sepiolite–Chitosan–Acetic Acid Biocomposite Attenuates the Development of Obesity and Nonalcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet. Nutrients. https://doi.org/10.3390/nu16223958
Vancouver
Niv D, Anavi E, Yaval L, Abbas A, Rytwo G, Gutman R. Sepiolite–Chitosan–Acetic Acid Biocomposite Attenuates the Development of Obesity and Nonalcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet. Nutrients. 2024. doi:10.3390/nu16223958
BibTeX
@article{Niv2024,
author = {Niv, Dalia and Anavi, Eli and Yaval, Laris and Abbas, Atallah and Rytwo, Giora and Gutman, Roee},
title = {Sepiolite–Chitosan–Acetic Acid Biocomposite Attenuates the Development of Obesity and Nonalcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16223958}
}
EUVIMED